| About | Followers 5 | Reviews | Exhibitors | Photos | Speakers | Travel Deals |
"Conference with the theme translational medicine clinical immunology and immunotherapy for viral hepatitis"
APASL Single Topic Conference is concentrating recently on the theme of Translational Medicine, Clinical Immunology and Immunotherapy for Viral Hepatitis. The conference is primarily about the discussions of liver diseases which are continuously increasing, including Chronic Hepatitis B, Liver Cirrhosis, Liver Failure and HCC, this wide spread of diseases is driven by two major factors, namely, virological and immunological factors. APASL Single Topic Conference will be looking upon these challenges and unsolved dead ends in clinical immunology of liver diseases which is becoming one of the most popularly discussed topics in gastroenterology and hepatology. The conference throws adequate light on all the concerned aspects of liver diseases.
Timings01:30 PM - 05:30 PM (Dec 12) (General)08:30 AM - 07:00 PM (Dec 13) (General)
07:30 AM - 05:00 PM ( Dec 14)
(General)
View More | Entry FeesPaid Ticket Starts from 100 USD View Details |
Participants100 - 500 Delegates Based on previous editions | Category & TypeConferenceMedical & Pharma |
EditionsDec 2014 17th EditionFrequency Not Available | Official LinksWebsiteContactsReport Error Claim this event |
| Different Located Editions Baku, Azerbaijan27 - 28 Jun 2019 9 Followers Beijing, China06 - 08 Dec 2018 4 Followers Taipei, Taiwan22 - 24 Jun 2018 2 Followers Istanbul, Turkey22 - 24 Sep 2016 5 Followers | |
Organizer Follow Company | |
User Community [ Users who have shown interest for this Event ]
Yaser Alahmadi
Pharmacist at Moh
Medina, Saudi Arabia
Dr. Harmeet Kaur
Jalandhar, India
Polrat Wilairatana
Professor at Mahidol University
Bangkok, Thailand
Sandy Liaw
Director at Novira Therapeutics
San Rafael, United StatesDr. Dipendra Raj Pandeya
Asst. Prof at Nepalese Army Institute Of Health Sciences
Kathmandu, NepalWrite a Review
Add Your ReviewSchedule & Agenda
| Fri, 12 Dec 01:30 PM - 01:50 PM | POSTGRADUATE COURSE:ELIMINATION OF MOTHER TO INFANT TRANSMISSION OF HEPATITIS B IN THE NEW ERA Course Directors: Hui Zhuang, Ding-Shinn Chen Perinatal transmission of HBV: prevalence, mechanism and risk factors | |
| Fri, 12 Dec 01:50 PM - 02:10 PM | POSTGRADUATE COURSE:ELIMINATION OF MOTHER TO INFANT TRANSMISSION OF HEPATITIS B IN THE NEW ERA Course Directors: Hui Zhuang, Ding-Shinn Chen Management of patients with HBV infection planning or have been in pregnancy: East versus West | |
| Fri, 12 Dec 02:10 PM - 02:30 PM | POSTGRADUATE COURSE:ELIMINATION OF MOTHER TO INFANT TRANSMISSION OF HEPATITIS B IN THE NEW ERA Course Directors: Hui Zhuang, Ding-Shinn Chen Antiretroviral pregnancy registry in US | |
| Fri, 12 Dec 02:30 PM - 02:50 PM | POSTGRADUATE COURSE:ELIMINATION OF MOTHER TO INFANT TRANSMISSION OF HEPATITIS B IN THE NEW ERA Course Directors: Hui Zhuang, Ding-Shinn Chen Elimination of perinatal transmission of HBV: have we accomplished this goal? | |
| Fri, 12 Dec 02:50 PM - 03:00 PM | POSTGRADUATE COURSE:ELIMINATION OF MOTHER TO INFANT TRANSMISSION OF HEPATITIS B IN THE NEW ERA Course Directors: Hui Zhuang, Ding-Shinn Chen Panel Discussion | |
| Fri, 12 Dec 03:30 PM - 04:10 PM | OUTSTANDING HEPATOLOGIST FORUM: THE ROAD TO MASTERS OF LIVER DISEASE Course Directors: George Lau, Masao Omata Eradication of HBV Infection Worldwide and Issues of Immune Tolerance | |
| Fri, 12 Dec 04:10 PM - 04:50 PM | OUTSTANDING HEPATOLOGIST FORUM: THE ROAD TO MASTERS OF LIVER DISEASE Course Directors: George Lau, Masao Omata My 30-year career in hepatitis B research: looking back and hopes for the future | |
| Fri, 12 Dec 04:50 PM - 05:30 PM | OUTSTANDING HEPATOLOGIST FORUM: THE ROAD TO MASTERS OF LIVER DISEASE Course Directors: George Lau, Masao Omata How do we evaluate your manuscript? | |
| Sat, 13 Dec 08:30 AM - 09:00 AM | Opening | |
| Sat, 13 Dec 09:00 AM - 09:30 AM | STATE-OF-THE-ART LECTURE:GUIDELINES AND CLINICAL PRACTICE Moderators: Lanjuan Li, Shiv K. Sarin The process and principles of guideline development: my personal experience | |
| Sat, 13 Dec 09:30 AM - 10:00 AM | STATE-OF-THE-ART LECTURE:GUIDELINES AND CLINICAL PRACTICE Moderators: Lanjuan Li, Shiv K. Sarin Management of chronic Hepatitis B: Applying guidelines to Clinical Practice | |
| Sat, 13 Dec 10:00 AM - 10:30 AM | STATE-OF-THE-ART LECTURE:GUIDELINES AND CLINICAL PRACTICE Moderators: Lanjuan Li, Shiv K. Sarin The evidence supporting guideline: contirbution from China | |
| Sat, 13 Dec 11:00 AM - 11:20 AM | OFFICIAL SYMPOSIUM 1 NATURAL HISTORY AND EPIDEMIOLOGY Moderators: Yumei Wen, A Kadir Dokmeci Prevention of HBV infection and liver cancer: current status and future challenge | |
| Sat, 13 Dec 11:00 AM - 11:20 AM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 2 CELL-BASED THERAPY FOR LIVER DISEASE Moderators: Jun Cheng, T. Jake Liang Overview of cell-based therapy: opportunity and chanllenge | |
| Sat, 13 Dec 11:00 AM - 11:20 AM | Venue: Qinghe Hall SPECIAL COURSE 1 HCC and Hepatitis Moderators: Jinlin Hou Pahogenesis of HBV related HCC | |
| Sat, 13 Dec 11:20 AM - 11:40 AM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 2 CELL-BASED THERAPY FOR LIVER DISEASE Moderators: Jun Cheng, T. Jake Liang Immunotherapy of HCC using T cells redirected against HBV | |
| Sat, 13 Dec 11:20 AM - 11:40 AM | Venue: Qinghe Hall SPECIAL COURSE 1 HCC and Hepatitis Moderators: Jinlin Hou Treatment indication of HCC - medical, surgical or radiation? | |
| Sat, 13 Dec 11:40 AM - 12:00 PM | OFFICIAL SYMPOSIUM 1 NATURAL HISTORY AND EPIDEMIOLOGY Moderators: Yumei Wen, A Kadir Dokmeci HBV Pre-C/BCP Mutations in Natural History of Chronic HBV Infection | |
| Sat, 13 Dec 11:40 AM - 12:00 PM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 2 CELL-BASED THERAPY FOR LIVER DISEASE Moderators: Jun Cheng, T. Jake Liang Standardization of cell-based therapy for liver disease | |
| Sat, 13 Dec 11:40 AM - 12:00 PM | Venue: Qinghe Hall SPECIAL COURSE 1 HCC and Hepatitis Moderators: Jinlin Hou The latest development of the treatment of HCC | |
| Sat, 13 Dec 12:00 PM - 12:20 PM | OFFICIAL SYMPOSIUM 1 NATURAL HISTORY AND EPIDEMIOLOGY Moderators: Yumei Wen, A Kadir Dokmeci Risk factors and etiology of liver failure in China | |
| Sat, 13 Dec 12:00 PM - 12:20 PM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 2 CELL-BASED THERAPY FOR LIVER DISEASE Moderators: Jun Cheng, T. Jake Liang Immune cell adoptive transfer for HCC therapy | |
| Sat, 13 Dec 12:20 PM - 12:30 PM | OFFICIAL SYMPOSIUM 1 NATURAL HISTORY AND EPIDEMIOLOGY Moderators: Yumei Wen, A Kadir Dokmeci Discussion | |
| Sat, 13 Dec 12:20 PM - 12:30 PM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 2 CELL-BASED THERAPY FOR LIVER DISEASE Moderators: Jun Cheng, T. Jake Liang Discussion | |
| Sat, 13 Dec 12:30 PM - 02:00 PM | LUNCH SYMPOSIUM | |
| Sat, 13 Dec 02:00 PM - 02:20 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 3:IMPACT OF ANTIVIRAL TREATMENT ON DISEASE OUTCOME Moderators: Xinhua Weng, Pietro Lampertico Reversal of cirrhosis through long-term antiviral therapy: histological evidence | |
| Sat, 13 Dec 02:00 PM - 02:20 PM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 4: NOVEL PLATFORM FOR DRUG DEVELOPMENT AGAINST HBV INFECTION Moderators: Guiqiang Wang, George K.K. Lau Experimental models for HBV study and drug development | |
| Sat, 13 Dec 02:00 PM - 02:15 PM | Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams Policy and strategies in India | |
| Sat, 13 Dec 02:15 PM - 02:30 PM | Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams Policy and strategies in Indonesia | |
| Sat, 13 Dec 02:20 PM - 02:40 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 3:IMPACT OF ANTIVIRAL TREATMENT ON DISEASE OUTCOME Moderators: Xinhua Weng, Pietro Lampertico How did antiviral therapy change the natural history of chronic hepatitis B? | |
| Sat, 13 Dec 02:20 PM - 02:40 PM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 4: NOVEL PLATFORM FOR DRUG DEVELOPMENT AGAINST HBV INFECTION Moderators: Guiqiang Wang, George K.K. Lau Entry inhibitors for the treatment of acute and chronic hepatitis B and hepatitis D virus infections | |
| Sat, 13 Dec 02:30 PM - 02:45 PM | Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams Policy and strategies in Mongolia | |
| Sat, 13 Dec 02:40 PM - 03:00 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 3:IMPACT OF ANTIVIRAL TREATMENT ON DISEASE OUTCOME Moderators: Xinhua Weng, Pietro Lampertico Occurrence of HCC in the era of antiviral therapy: complete elimination or reduction | |
| Sat, 13 Dec 02:40 PM - 03:00 PM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 4: NOVEL PLATFORM FOR DRUG DEVELOPMENT AGAINST HBV INFECTION Moderators: Guiqiang Wang, George K.K. Lau Eradication of HBV: can we eliminate cccDNA? | |
| Sat, 13 Dec 02:45 PM - 03:00 PM | Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams Policy and strategies in Philippines | |
| Sat, 13 Dec 03:00 PM - 03:20 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 3:IMPACT OF ANTIVIRAL TREATMENT ON DISEASE OUTCOME Moderators: Xinhua Weng, Pietro Lampertico HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability | |
| Sat, 13 Dec 03:00 PM - 03:20 PM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 4: NOVEL PLATFORM FOR DRUG DEVELOPMENT AGAINST HBV INFECTION Moderators: Guiqiang Wang, George K.K. Lau Target for the design of new antiviral agent | |
| Sat, 13 Dec 03:00 PM - 03:15 PM | Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams Policy and strategies in Taiwan | |
| Sat, 13 Dec 03:15 PM - 03:30 PM | Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams Policy and strategies in Japan | |
| Sat, 13 Dec 03:20 PM - 03:30 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 3:IMPACT OF ANTIVIRAL TREATMENT ON DISEASE OUTCOME Moderators: Xinhua Weng, Pietro Lampertico Discussion | |
| Sat, 13 Dec 03:20 PM - 03:30 PM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 4: NOVEL PLATFORM FOR DRUG DEVELOPMENT AGAINST HBV INFECTION Moderators: Guiqiang Wang, George K.K. Lau Discussion | |
| Sat, 13 Dec 03:30 PM - 03:45 PM | Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams Policy and strategies in Korea | |
| Sat, 13 Dec 03:45 PM - 04:00 PM | Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams Policy and strategies in China | |
| Sat, 13 Dec 04:00 PM - 04:20 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 5 CURRENT ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B Moderators: Jidong Jia, Henry L.Y. Chan Cure of hepatitis B with antiviral therapy: Reality or not | |
| Sat, 13 Dec 04:00 PM - 05:30 PM | Venue: Guangdong Hall APASL RISING STAR PRESENTATION | |
| Sat, 13 Dec 04:20 PM - 04:40 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 5 CURRENT ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B Moderators: Jidong Jia, Henry L.Y. Chan IFN-based optimization strategy for the treatment of chronic hepatitis B | |
| Sat, 13 Dec 04:30 PM - 04:50 PM | Venue: Qinghe Hall SPECIAL COURSE 3 NAFLD and Hepatitis Moderators: Zhongping Duan NAFLD and Hepatitis B | |
| Sat, 13 Dec 04:40 PM - 05:00 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 5 CURRENT ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B Moderators: Jidong Jia, Henry L.Y. Chan NUC- based optimization strategy for the treatment of chronic hepatitis B | |
| Sat, 13 Dec 04:50 PM - 05:10 PM | Venue: Qinghe Hall SPECIAL COURSE 3 NAFLD and Hepatitis Moderators: Zhongping Duan NAFLD and hepatitis C | |
| Sat, 13 Dec 05:00 PM - 05:20 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 5 CURRENT ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B Moderators: Jidong Jia, Henry L.Y. Chan Pathogenesis and treatment of hepatitis B related liver failure | |
| Sat, 13 Dec 05:10 PM - 05:30 PM | Venue: Qinghe Hall SPECIAL COURSE 3 NAFLD and Hepatitis Moderators: Zhongping Duan NAFLD and non-liver diseases | |
| Sat, 13 Dec 05:20 PM - 05:30 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 5 CURRENT ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B Moderators: Jidong Jia, Henry L.Y. Chan Discussion | |
| Sat, 13 Dec 05:30 PM - 07:30 PM | DINNER SYMPOSIUM | |
| Sat, 13 Dec 11:20 PM - 11:40 PM | OFFICIAL SYMPOSIUM 1 NATURAL HISTORY AND EPIDEMIOLOGY Moderators: Yumei Wen, A Kadir Dokmeci New findings from past decade: What have HBV cohort studies revealed. | |
| Sun, 14 Dec 07:30 AM - 07:50 AM | Venue: Lingnan Hall BREAKFAST WORKSHOP:NEW ERA OF FIBROSIS ASSESMENT Moderators:Qing Xie, Mark Thursz Quantitative assessment of fibrosis in liver biopsy: from basic to clinical application | |
| Sun, 14 Dec 07:50 AM - 08:10 AM | Venue: Lingnan Hall BREAKFAST WORKSHOP:NEW ERA OF FIBROSIS ASSESMENT Moderators:Qing Xie, Mark Thursz Non-invasive assessment of liver fibrosis: Can one size fit all? | |
| Sun, 14 Dec 08:10 AM - 08:30 AM | Venue: Lingnan Hall BREAKFAST WORKSHOP:NEW ERA OF FIBROSIS ASSESMENT Moderators:Qing Xie, Mark Thursz Application of non-invasive tests to clinical practice | |
| Sun, 14 Dec 08:30 AM - 08:50 AM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 6:MANAGEMENT OF SUBOPTIMAL RESPONDERS AND RESISTANCE Moderators:Xiaoguang Dou, Harry Janssen New insight into nucleot(s)ide analogues-resistance mechanisms | |
| Sun, 14 Dec 08:30 AM - 08:50 AM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 7:IMMUNE THERAPEUTIC STRATEGIES IN CHRONIC HBV INFECTION Course Directors: Fusheng Wang, Massimo Levrero New roles of alum in therapeutic vaccination | |
| Sun, 14 Dec 08:50 AM - 09:10 AM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 6:MANAGEMENT OF SUBOPTIMAL RESPONDERS AND RESISTANCE Moderators:Xiaoguang Dou, Harry Janssen Management of suboptimal responders: from clinical trial to clinical practice | |
| Sun, 14 Dec 08:50 AM - 09:10 AM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 7:IMMUNE THERAPEUTIC STRATEGIES IN CHRONIC HBV INFECTION Course Directors: Fusheng Wang, Massimo Levrero Immunopathogenesis of chronic HBV infection: whatu2019s New? | |
| Sun, 14 Dec 09:10 AM - 09:30 AM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 6:MANAGEMENT OF SUBOPTIMAL RESPONDERS AND RESISTANCE Moderators:Xiaoguang Dou, Harry Janssen Management and Prevention of drug resistance | |
| Sun, 14 Dec 09:10 AM - 09:30 AM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 7:IMMUNE THERAPEUTIC STRATEGIES IN CHRONIC HBV INFECTION Course Directors: Fusheng Wang, Massimo Levrero Th cell differentitation and viral infection | |
| Sun, 14 Dec 09:30 AM - 09:50 AM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 6:MANAGEMENT OF SUBOPTIMAL RESPONDERS AND RESISTANCE Moderators:Xiaoguang Dou, Harry Janssen Global network for resistance surveillance | |
| Sun, 14 Dec 09:30 AM - 09:50 AM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 7:IMMUNE THERAPEUTIC STRATEGIES IN CHRONIC HBV INFECTION Course Directors: Fusheng Wang, Massimo Levrero Targeting innate HBV immunity: TLR agonists | |
| Sun, 14 Dec 09:50 AM - 10:00 AM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 6:MANAGEMENT OF SUBOPTIMAL RESPONDERS AND RESISTANCE Moderators:Xiaoguang Dou, Harry Janssen Discussion | |
| Sun, 14 Dec 09:50 AM - 10:00 AM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 7:IMMUNE THERAPEUTIC STRATEGIES IN CHRONIC HBV INFECTION Course Directors: Fusheng Wang, Massimo Levrero Discussion | |
| Sun, 14 Dec 10:30 AM - 10:50 AM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 8:REVISITING THE TREATMENT RECOMMENDATION BY GUIDELINES Moderators: Lai Wei, Jia-Horng Kao Do guidelines preclude hepatitis B patients from receiving treatment? | |
| Sun, 14 Dec 10:30 AM - 10:50 AM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 9:HEPATOCELLULAR CARCINOMA AND GENETICS Moderators: Yuming Wang, Dong Jin Suh Genetic study of liver diseases | |
| Sun, 14 Dec 10:50 AM - 11:10 AM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 8:REVISITING THE TREATMENT RECOMMENDATION BY GUIDELINES Moderators: Lai Wei, Jia-Horng Kao What evidence to support antiviral therapy in children? | |
| Sun, 14 Dec 10:50 AM - 11:10 AM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 9:HEPATOCELLULAR CARCINOMA AND GENETICS Moderators: Yuming Wang, Dong Jin Suh GWAS study in HBV infection | |
| Sun, 14 Dec 11:10 AM - 11:30 AM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 8:REVISITING THE TREATMENT RECOMMENDATION BY GUIDELINES Moderators: Lai Wei, Jia-Horng Kao Therapy for immune tolerant hepatitis B: our next target population? | |
| Sun, 14 Dec 11:10 AM - 11:30 AM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 9:HEPATOCELLULAR CARCINOMA AND GENETICS Moderators: Yuming Wang, Dong Jin Suh Mechanism of HBV related HCC | |
| Sun, 14 Dec 11:30 AM - 11:50 AM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 8:REVISITING THE TREATMENT RECOMMENDATION BY GUIDELINES Moderators: Lai Wei, Jia-Horng Kao What is missing in APASL guideline | |
| Sun, 14 Dec 11:30 AM - 11:50 AM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 9:HEPATOCELLULAR CARCINOMA AND GENETICS Moderators: Yuming Wang, Dong Jin Suh Role of HBV integration in the pathogenesis of hepatocellular carcinoma | |
| Sun, 14 Dec 11:50 AM - 12:00 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 8:REVISITING THE TREATMENT RECOMMENDATION BY GUIDELINES Moderators: Lai Wei, Jia-Horng Kao Discussion | |
| Sun, 14 Dec 11:50 AM - 12:00 PM | Venue: Guangdong Hall OFFICIAL SYMPOSIUM 9:HEPATOCELLULAR CARCINOMA AND GENETICS Moderators: Yuming Wang, Dong Jin Suh Discussion | |
| Sun, 14 Dec 12:00 PM - 01:30 PM | LUNCH SYMPOSIUM | |
| Sun, 14 Dec 01:30 PM - 01:50 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 10:-ANTIVIRAL TREATMENT IN SPECIAL POPULATION Moderators: Fengmin Lu, Stephen Locarnini Update on the management of immune suppressed patients | |
| Sun, 14 Dec 01:30 PM - 01:50 PM | Venue: Guandgong Hall OFFICIAL SYMPOSIUM 11:STRATEGIES OF STOPPING TREATMENT Moderators: Zhiliang Gao, Teerha Pirativisuth Is it possible to achieve sustained off-treatment response by switching NUC to IFN | |
| Sun, 14 Dec 01:50 PM - 02:10 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 10:-ANTIVIRAL TREATMENT IN SPECIAL POPULATION Moderators: Fengmin Lu, Stephen Locarnini Coinfection of HBV and HIV | |
| Sun, 14 Dec 01:50 PM - 02:10 PM | Venue: Guandgong Hall OFFICIAL SYMPOSIUM 11:STRATEGIES OF STOPPING TREATMENT Moderators: Zhiliang Gao, Teerha Pirativisuth Revising the stopping rule of guideline recommendation for NUC-treated patients | |
| Sun, 14 Dec 02:10 PM - 02:30 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 10:-ANTIVIRAL TREATMENT IN SPECIAL POPULATION Moderators: Fengmin Lu, Stephen Locarnini Role of peginterferon plus ribavirin in the current regime of hepatitis C therapy in Asia-Pacific area? | |
| Sun, 14 Dec 02:10 PM - 02:30 PM | Venue: Guandgong Hall OFFICIAL SYMPOSIUM 11:STRATEGIES OF STOPPING TREATMENT Moderators: Zhiliang Gao, Teerha Pirativisuth Stopping rules for patients treated with IFN | |
| Sun, 14 Dec 02:30 PM - 02:50 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 10:-ANTIVIRAL TREATMENT IN SPECIAL POPULATION Moderators: Fengmin Lu, Stephen Locarnini The role of DAA in the treatment of chronic hepatitis C: WEST versus EAST | |
| Sun, 14 Dec 02:30 PM - 02:50 PM | Venue: Guandgong Hall OFFICIAL SYMPOSIUM 11:STRATEGIES OF STOPPING TREATMENT Moderators: Zhiliang Gao, Teerha Pirativisuth Stopping treatment: a practical and unmet medical need in Asia | |
| Sun, 14 Dec 02:50 PM - 03:00 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 10:-ANTIVIRAL TREATMENT IN SPECIAL POPULATION Moderators: Fengmin Lu, Stephen Locarnini Discussion | |
| Sun, 14 Dec 02:50 PM - 03:00 PM | Venue: Guandgong Hall OFFICIAL SYMPOSIUM 11:STRATEGIES OF STOPPING TREATMENT Moderators: Zhiliang Gao, Teerha Pirativisuth Discussion | |
| Sun, 14 Dec 03:30 PM - 03:50 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 12:PERSPECTIVE FOR THE TREATMENT OF CHRONIC HEPATITIS B IN THE COMING DECADES Course Directors: Zhenghong Yuan, Stephan Urban | |
| Sun, 14 Dec 03:30 PM - 05:00 PM | ORAL PRESENTATION | |
| Sun, 14 Dec 03:50 PM - 04:10 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 12:PERSPECTIVE FOR THE TREATMENT OF CHRONIC HEPATITIS B IN THE COMING DECADES Course Directors: Zhenghong Yuan, Stephan Urban Ongoing preclinical and clinical studies: New compound, New future | |
| Sun, 14 Dec 04:10 PM - 04:30 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 12:PERSPECTIVE FOR THE TREATMENT OF CHRONIC HEPATITIS B IN THE COMING DECADES Course Directors: Zhenghong Yuan, Stephan Urban HBV DNA suppression versus HBsAg seroclearance versus reduction of cccDNA as endpoint | |
| Sun, 14 Dec 04:30 PM - 04:50 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 12:PERSPECTIVE FOR THE TREATMENT OF CHRONIC HEPATITIS B IN THE COMING DECADES Course Directors: Zhenghong Yuan, Stephan Urban New biomarkers for efficacy prediction : new wine in old bottle | |
| Sun, 14 Dec 04:50 PM - 05:00 PM | Venue: Lingnan Hall OFFICIAL SYMPOSIUM 12:PERSPECTIVE FOR THE TREATMENT OF CHRONIC HEPATITIS B IN THE COMING DECADES Course Directors: Zhenghong Yuan, Stephan Urban Discussion | |
Visitor Ticket Price
| Group Registration (Ten people or more) | |
| 220 USD | Early Registration(2014-11-28) |
| 300 USD | Onsite |
| Accompanying Person | |
| 250 USD | Early Registration(2014-11-28) |
| 340 USD | Onsite |
| Trainee/Residents | |
| 100 USD | Early Registration(2014-11-28) |
| 150 USD | Onsite |
| Delegates | |
| 250 USD | Early Registration(2014-11-28) |
| 340 USD | Onsite |
| APASL Member | |
| 170 USD | Early Registration(2014-11-28) |
| 250 USD | Onsite |
23.186962113.278520
Venue Map & Directions
Baiyun International Convention Center
1039-1045 Baiyun S Ave BaiYun YinShi WenHua ChangLang Baiyun Qu Guangzhou Shi Guangdong Sheng 510405
China
Featured Hotels in Guangzhou
 | Guangzhou Baiyun International .. from CNY 498 |
 | Guangzhou Min Hang Li Da Hotel from CNY 0 |
 | Hilton Guangzhou Baiyun from CNY 612 |
 | Guangzhou Mairong Hotel from CNY 178 |
Connect, Meet and Build a Strong Network
Mar 222021
Mar 042021
